[et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” column_structure=”2_5,3_5″][et_pb_column type=”2_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”https://avicorbiotech.com/wp-content/uploads/2020/06/hvg.jpg” _builder_version=”4.5.1″ _module_preset=”default” title_text=”hvg” hover_enabled=”0″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.5.1″ _module_preset=”default” hover_enabled=”0″]

Avidin is developing potential drug candidate to combat Covid-19 reported by HVG

[/et_pb_text][et_pb_text _builder_version=”4.5.1″ _module_preset=”default” hover_enabled=”0″]

05/28/2020

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.5.1″ _module_preset=”default”][et_pb_column _builder_version=”4.5.1″ _module_preset=”default” type=”4_4″][et_pb_text _builder_version=”4.5.1″ _module_preset=”default” hover_enabled=”0″]

Avicor, reported by HVG (Weekly World Economy) the Hungarian leading economic and political weekly, is working on synthetizing potential drug candidate molecules which inhibit the enzyme responsible for the viral entry of Covid-19 together with a German company. The viral entry is an important step which is shared by Influenza virus thus the potential new drug would inhibit Influenza also. This would revolutionize the combat against the viruses which infect millions, responsible of the death of so many people worldwide and causing such a devastating burden on every society.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]